Cerus Corporation (CERS) Reports Fourth Quarter and Year-End 2012 Results
3/1/2013 7:09:53 AM
Cerus Corporation (NASDAQ: CERS) today announced financial results for the fourth quarter and year ended December 31, 2012.
"We believe 2013 will be a pivotal year for Cerus in which we plan to both complete our INTERCEPT plasma PMA submission and begin planning for the PMA filing for INTERCEPT platelets,“ said William "Obi" Greenman, president and chief executive officer of Cerus Corporation.
comments powered by